{"database": "lobbying", "table": "lobbying_activities", "rows": [[1227883, "c9bd38de-87f6-41f7-867d-2ae233e2bdfc", "Q1", "MEHLMAN CONSULTING, INC.", 284950, "NATIONAL VENTURE CAPITAL ASSOCIATION", 2012, "first_quarter", "MED", "FDA reform:  Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs.\nH.R. 4132, Faster Access to Specialized Treatments (FAST) Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act; H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011; S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012", "Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of", 60000, null, 0, 0, "2012-04-16T13:06:09.617000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1227883"], "units": {}, "query_ms": 0.837361003505066, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}